Published: Jan 11, 2022
On January 10, as reported by Indonesian National Agency of Drug and Food
Control (BPOM), adenovirus vector COVID-19 vaccine (KCONECAVAC) manufactured by
Shenzhen Kangtai Biological Products Co., Ltd. had been approved for emergency
use authorization (EUA) of homologous booster dose.
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
With global push for COVID-19 vaccines, China aims to win friends and cut deals